Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The company's Owkin Socrates platform applies transfer and federated learning to clinical research.
The deal follows the biopharma industry's growing interest in immuno-oncology.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM.
INC Research/inVentiv Health is now officially Syneos Health.
The $58 million financing round represents biopharma industry's growing interest in genomics data.
About a year after QuintilesIMS was born from a megamerger between Quintiles and IMS Health, the contract research giant has decided to turn the page.
Concept Life Sciences bought Acquila Biomedical for its translational biology capabilities.
A year after launching its Japanese business, Clinigen has bought Japan’s largest supplier of unlicensed medicines.
Novum Pharmaceutical Research Services has renovated its 34,000-square-foot early-phase clinic in Las Vegas.
WuXi AppTec buys U.S.-based full-service CRO ResearchPoint Global, tapping the latter's clinical operations in over 60 countries.